Hewings David S, Flygare John A, Wertz Ingrid E, Bogyo Matthew
Discovery Chemistry, Genentech, South San Francisco, CA, USA.
Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA.
FEBS J. 2017 May;284(10):1540-1554. doi: 10.1111/febs.14016. Epub 2017 Feb 7.
Proteasomes are multisubunit protease complexes responsible for degrading most intracellular proteins. In addition to removing damaged proteins, they regulate many important cellular processes through the controlled degradation of transcription factors, cell cycle regulators, and enzymes. Eukaryotic proteasomes have three catalytic subunits, β1, β2, and β5, that each has different substrate specificities. Additionally, although we know that diverse cell types express proteasome variants with distinct activity and specificity profiles, the functions of these different pools of proteasomes are not fully understood. Covalent inhibitors of the protease activity of the proteasome have been developed as drugs for hematological malignancies and are currently under investigation for other diseases. Therefore, there is a need for tools that allow direct monitoring of proteasome activity in live cells and tissues. Activity-based probes have proven valuable for biochemical and cell biological studies of the role of individual proteasome subunits, and for evaluating the efficacy and selectivity of proteasome inhibitors. These probes react covalently with the protease active sites, and contain a reporter tag to identify the probe-labeled proteasome subunits. This review will describe the development of broad-spectrum and subunit-specific proteasome activity-based probes, and discuss how these probes have contributed to our understanding of proteasome biology, and to the development of proteasome inhibitors.
蛋白酶体是负责降解大多数细胞内蛋白质的多亚基蛋白酶复合物。除了清除受损蛋白质外,它们还通过对转录因子、细胞周期调节因子和酶的可控降解来调节许多重要的细胞过程。真核生物蛋白酶体有三个催化亚基,β1、β2和β5,每个亚基都有不同的底物特异性。此外,虽然我们知道不同细胞类型表达具有不同活性和特异性谱的蛋白酶体变体,但这些不同类型蛋白酶体的功能尚未完全了解。蛋白酶体蛋白酶活性的共价抑制剂已被开发用作治疗血液系统恶性肿瘤的药物,目前正在针对其他疾病进行研究。因此,需要能够直接监测活细胞和组织中蛋白酶体活性的工具。基于活性的探针已被证明对研究单个蛋白酶体亚基的作用以及评估蛋白酶体抑制剂的疗效和选择性具有重要价值。这些探针与蛋白酶活性位点发生共价反应,并含有一个报告标签以识别被探针标记的蛋白酶体亚基。本综述将描述广谱和亚基特异性基于蛋白酶体活性的探针的发展,并讨论这些探针如何有助于我们对蛋白酶体生物学的理解以及蛋白酶体抑制剂的开发。